Biomarin Pharmaceutical Inc
NASDAQ: BMRN
$64.19
+$1.32 (+2.1%)
Closing Price on February 5, 2025
BMRN Articles
These four top Suntrust biotech picks for 2018 all have the potential for big upside moves if they do indeed exceed first-quarter expectations.
Published:
Last Updated:
These four top companies could be very attractive to large cap biotechs looking to add gene and cell therapy drugs to their portfolios.
Published:
Last Updated:
Merrill Lynch has taken a look at the biotech industry and made a few picks that could play out in 2018.
Published:
Last Updated:
Here 24/7 Wall St. has included a calendar of a few of the biggest companies expecting clinical trial and FDA updates in February.
Published:
Last Updated:
Credit Suisse sees tax reform sparking a wave of mergers in the emerging pharmaceuticals space, which could produce sector outperformance. The firm is cautiously optimistic on this front.
Published:
Last Updated:
The include Abercrombie & Fitch, Arch Coal, Baker Hughes, BioMarin Pharmaceutical, Gilead Sciences, Hasbro and Snap.
Published:
Last Updated:
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of July and added some color.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations include ConocoPhillips, Goodyear Tire, Humana, Lululemon Athletica and Range Resources.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday, include Best Buy, Caterpillar, Nokia, UnitedHealth and Wal-Mart.
Published:
Last Updated:
In a new report, SunTrust Robinson Humphrey analysts are focused on upcoming catalysts for biotech stocks in their coverage universe.
Published:
Last Updated:
BioMarin Pharmaceutical may have missed out on the Trump rally, but it might not be too late to catch a ride on the wave, at least according to one analyst.
Published:
Last Updated:
A recent research report from the biotech team at Baird offers their top picks for 2017. While hardly pounding the table, they are cautiously optimistic on the industry.
Published:
Last Updated:
In a new research report, the biotech team at RBC reveal their top picks for 2017, and while hardly pounding the table, they are cautiously optimistic.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include AK Steel, Celgene, Darden Restaurants, Delphi Automotive, Johnson & Johnson and U.S. Steel.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday morning include GoPro, Randgold Resources, Teva Pharmaceutical, Time Warner, Waste Management.
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.